Enzymatic Assay of Opioid Analgesic, Tramadol, Using Horseradish Peroxidase

Article Preview

Abstract:

Three novel and sensitive enzymatic methods have been developed for the quantification of tramadol in pharmaceutical dosage forms. The proposed methods are based on the reaction of tramadol with 3-methylbenzothiazoline-2-one hydrazone (method A), aniline (method B) and aminoantipyrine in the presence of hydrogen peroxide and horseradish peroxidase to give colored complexes. The colored complexes obtained with 3-methylbenzothiazoline-2-one hydrazone, aniline and aminoantipyrine exhibit absorption maxima at 480 nm, 550 nm and 530 nm, respectively. Regression analysis of Beer’s plots showed good correlation for tramadol in the concentration range (μg/mL) 2-12 for the methods A & B and 4-24 for the method C. The experimental parameters were studied and optimized. The precision and accuracy of the methods were satisfactory. The proposed methods were successfully applied for the quantification of tramadol in 3 brands of commercially available tablet dosage forms. The results were compared satisfactorily with the official method.

Info:

[1] P. Dayer, J. Desmeules, L. Collart, Drugs 53 (1997) 18-24.

Google Scholar

[2] K. S. Lewis, N. H. Han, American Journal of Health - System Pharmacy 54 (1997) 643-352.

Google Scholar

[3] L. Costa, F. Barros, F. Pedro, C. Dias, European Journal of Anaesthesiology 13 (1996 199-200.

Google Scholar

[4] F. Coluzzi, C. Mattia, Therapeutics and Clinical Risk Management  3 (2007) 819-829.

Google Scholar

[5] AS. Stephan, Therapeutics and Clinical Risk Management 3 (2007) 717-723.

Google Scholar

[6] L. Adler, C. McDonald, C. O'Brien, M. Wilson, The Journal of Rheumatology 29 (2002) 2196-2199.

Google Scholar

[7] G. Mongin, Expert Review of Neurotherapeutics 7 (2007) 1775-1784.

Google Scholar

[8] H. H. Hennies, E. Friderichs, J. Schneider, Arzneimittel-Forschung 38 (1988) 877-880.

Google Scholar

[9] M. C. Frink, H. H. Hennies, W. Englberger, M. Haurand, B. Wilffert, Arzneimittel- Forschung 46 (1996) 1029-1036.

Google Scholar

[10] P. Dayer, J. Desmeules, L. Collart, Drugs 53 (1997) 18-24.

Google Scholar

[11] B. Driessen, W. Reimann, British Journal of Pharmacology 105 (1992) 147-151.

Google Scholar

[12] T. A. Bamigbade, C. Davidson, R. M. Langford, J. A. Stamford, British Journal of Anaesthesia 79 (1997) 352.356.

Google Scholar

[13] W. Reimann, F. Schneider, European Journal of Pharmacology 349 (1998) 199-203.

Google Scholar

[14] M. Gobbi, M. Moia, L. Pirona, I. Ceglia, M. Reyes-Parada, C. Scorza, T. Mennini, Journal of Neurochemistry 82 (2002) 1435-1443.

DOI: 10.1046/j.1471-4159.2002.01073.x

Google Scholar

[15] European Pharmacopoeia, 5th Edi., European Department for the Quality of Medicines within the Council of Europe, Strasbourg, 2005, p.2607.

Google Scholar

[16] H. E. Abdellatef, M. M. El-Henawee, H. M. El-Sayed, M.M. Ayad, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 65 (2006) 1087-1092.

DOI: 10.1016/j.saa.2006.02.008

Google Scholar

[17] A. Küçüka, Y. Kadıoğlub, II Farmaco 60 (2005) 163-169.

Google Scholar

[18] A. Curticapean, D. Munteana, M. Curticapeana, M. Dogarua, C. Vari, Journal of Biochemical and Biophysical Methods 70 (2008) 1304-1312.

Google Scholar

[19] Y. Geng-Chang, S. Ming-Thau, Y. Chia-Lin, W. Ya-Wen, L. Cheng-Hsiung, H. Hsiu-O., Journal of Chromatography B: Biomedical Sciences and Applications 723 (1999) 247-253.

Google Scholar

[20] S. H. Gan, R. Ismail, W. A. Wan Adnan, Z. Wan, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 772 (2008) 123-129.

Google Scholar

[21] Y. H. Ardakani, Md. Reza Rouini, Journal of Pharmaceutical and Biomedical Analysis 44 (2007) 1168-1173.

Google Scholar

[22] M. Nobilis, J. Kopecký, J. Kvtina, J. Chládek, Z. Svoboda, V. Voíek, F. Perlík, M. Pour, J. Kune, Journal of Chromatography A 949 (2002) 11-22.

Google Scholar

[23] M. A. Campanero, E. García-Quetglas, B. Sádaba, J. R. Azanza, Journal of Chromatography 1031 (2004) 219-228..

Google Scholar

[24] M. De Leo, M. Giorgi, G. Saccomanni, C. Manera, A. Braca, C:\pmid:19072864Rapid Communications in Mass Spectrometry 23 (2009) 228-236.

DOI: 10.1002/rcm.3870

Google Scholar

[25] H. M. Abu-Shawish, N. A. Ghalwa, F. R. Zaggout, S.M. Saadeh, A.R. Al-Dalou, A.A. Abou Assi, Biochemical Engineering Journal 48 (2010) 237-245.

DOI: 10.1016/j.bej.2009.10.019

Google Scholar

[26] M. R. Ganjali, T. Razavi, F. Faridbod, S. Riahi, P. Norouzi, Current Pharmaceutical Analysis 5 (2009) 28-33.

Google Scholar

[27] EMPJ. Garrido, JMPJ. Garrido, F. Borges, C. Delerue-Matos, Journal of Pharmaceutical and Biomedical Analysis 32 (2003) 975-981.

DOI: 10.1016/s0731-7085(03)00199-7

Google Scholar

[28] M. Merslavič, L. Zupančič-Kralj, Journal of Chromatography B: Biomedical Sciences and Applications 693 (1997) 222-227.

DOI: 10.1016/s0378-4347(97)00066-2

Google Scholar

[29] Y. F. Sha, S. Shen, G. L. Duan, Journal of Pharmaceutical and Biomedical Analysis 37 (2005) 143-147.

Google Scholar

[30] Q. Tao, D. J. Stone, M. R. Borenstein, V. Jean-Bart, E. E. Codd, T.P. Coogan, D. Desai-Krieger, S. Liao, RB. Raffa, Journal of Chromatography B: Biomedical Science Applications 763 (2001) 165-171.

DOI: 10.1016/s0378-4347(01)00388-7

Google Scholar

[31] S. N. Meyyanathan, P. Kumar, B. Suresh, Journal of Separation Science 26 (2003) 1359-1362.

Google Scholar

[32] K. Venkateshwarlu, Y. N. Reddy, K. Srisailam, V. Rajkumar, M. G. Pai, Current Trends in Biotechnology and Pharmacy 2 (2008) 421-425.

Google Scholar

[33] J. Krzek, M. Starek, Biomedical Chromatography 18 (2004) 589-599.

Google Scholar

[34] H. E. Abdellatef, Journal of Pharmaceutical and Biomedical Analysis 29 (2002) 835-842.

Google Scholar

[35] A. Kumar, S. Nanda, R. Chomwal, The Indian Pharmacist 8 (2010) 85-87.

Google Scholar

[36] R. Kalaichelvi, E. Jayachandran, Research Journal of Pharmacy and Technology 3 (2010) 1096-1099

Google Scholar

[37] Validation of Analytical Procedures, Methodology, International Conference on Harmonization (ICH): Text and Methodology Q2 (R 1): Complementary Guideline on Methodology dated 06 November 1996: incorporated in November 2005, London.

Google Scholar

[38] H. U. Bergmeyer, Methods of Enzymic Analysis, Academic Press, 1965, p.895.

Google Scholar

[39] P. Nagaraja, A. Shivakumar, A. K. Shrestha, Analytical Biochemistry 395 (2009) 231-236.

Google Scholar

[40] S. Leonardo, S. Sara, D. A. Igor, G. P. Pier, Enzyme and Microbial Technology 22 (1998) 656-661.

Google Scholar

[41] Z. Huixian, K. E. Taylor, Chemosphere 28 (1994) 1807-1817.

Google Scholar

[42] C. B. Sekaran, C. R., Babu, B. P. Kumar, D. R. Shankar, Journal of Pure and Applied Microbiology 2 (2008) 257-259.

Google Scholar

[43] C. B. Sekaran, S. V. Saradhi, Biotechnology Biosciences Research Asia 5 (2008) 258-261.

Google Scholar

[44] C. B. Sekaran, S. V. Saradhi, B. P. Kumar, Ch. Srilakshmi, Asian Journal of Chemistry 21 (2009) 6647-6650.

Google Scholar

[45] A. P. Rani, C. B. Sekaran, Ch. Srilakshmi, Biomedical and Pharmacology Journal 2 (2009) 91-94. ( Received 13 May 2014; accepted 21 May 2014 )

Google Scholar